How can you support your patients living with obesity and cardiovascular (CV) risk?

Credit available for this activity expires: 12/18/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999294?ecd=bdc_podcast_libsyn_mscpedu

Your patient has endured surgery, radiation therapy, and chemotherapy. After all that, how do you discuss the risk of recurrence and additional treatment?    Credit available for this activity expires: 12/15/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999193?ecd=bdc_podcast_libsyn_mscpedu

How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence?

Credit available for this activity expires: 12/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999101?ecd=bdc_podcast_libsyn_mscpedu

Did you know that different types of drug resistance to antibody-drug conjugates (ADCs) can develop at different sites in the same patient? How may this impact ADC sequencing?

Credit available for this activity expires: 12/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999152?ecd=bdc_podcast_libsyn_mscpedu

Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing.

Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to appropriately incorporate syndromic testing into patient care? Hear from the experts.   Credit available for this activity expires: [12/11/24] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999156 ?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on latest data on biologics in spondyloarthritis and the recent EULAR treatment recommendation updates? Join us to find out more!

Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998991?ecd=bdc_podcast_libsyn_mscpedu

Did you know that the National Comprehensive Cancer Network (NCCN) guidelines now include an investigational noncovalent BTK inhibitor for the treatment of relapsed/refractory CLL?    Credit available for this activity expires: 12/05/24 Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/viewarticle/998747?ecd=bdc_podcast_libsyn_mscpedu

Join our experts to hear about imaging strategies to determine cardiovascular (CV) risk and optimum preventive strategies.    Credit available for this activity expires: 12/5/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998954?ecd=bdc_podcast_libsyn_mscpedu

Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH).    Credit available for this activity expires: 12/4/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/998939?ecd=bdc_podcast_libsyn_mscpedu